Mr. John O'Bireck reports

SPARTA LAUNCHES AUTONOMOUS MEDICINE PROJECT TO CREATE MEDICAL DECISION SUPPORT FOR TRANSFORMATIONAL HEALTHCARE DELIVERY IN CHALLENGING LOCATIONS

Sparta Capital Ltd. is launching an autonomous medicine project, bringing together several of the company's technology partners to potentially transform health care delivery in situations where access to medical assistance is limited or slow, including remote areas like Canada's northern territories.

When complete, the project is expected to offer health care professionals a medical decision support software that is Health Canada/Food and Drug Administration approved as a medical device and is capable of autonomously diagnosing illness and prescribing treatment. The project is initiated through Sparta's newly formed division, Sparta Health Corp.

"This final product is meant to support doctors, nurses or other health care professionals, as they work to serve patients effectively and efficiently. With our system, we expect that more people will not only receive quicker access to the medical help they need, the information provided will be based on the world's most current medical evidence," said John O'Bireck, president and chief technology officer of Sparta.

Sparta's autonomous medicine system (AMS, or Doc-in-a-Box) originated in a 2013 Canadian Space Agency (CSA) concept study, specifically a manned exploration to Mars. A video demonstrates future possibilities of such a system, but the study confirmed its feasibility. Two of the authors of the study are now valued members of Sparta's technical advisory board (TAB) and continue to work on developing various key components of the system. Sparta's newly formed Sparta Health is working to carry the transformative technology over the finish line.

During a medical incident Doc-in-a-Box can be used by a trained medical observer, such as an EMT (emergency medical technician), nurse or physician. Essentially, the medical professional is guided in the collection of symptoms, thus allowing the technology to establish a diagnosis and subsequent treatment because it has relied on the most up-to-date evidence-based medicine. Analogous to the recently popularized ChatGPT platform, Doc-in-a-Box applies a similar form of natural language processing (NLP). In this case, to medical guidelines and clinical research to maintain a current knowledge base.

The AMS project has various stages to go through before being deemed a medical device, including production of an SaMD (software-as-a-medical-device), as well as procedural and test data submissions to Health Canada. Sparta management expects the development and integration process to take between 12 and 24 months. The intent is to meet with the investment community in the next month to secure the balance of the necessary financing.

"The demand for health care access continues to grow due to an aging population and chronic shortage of medical professionals in remote areas. At Sparta, we see these challenges, as an exciting opportunity to deliver creative solutions," Mr. O'Bireck added.

About Sparta Capital Ltd.

Sparta is leading a green revolution in the business world with advanced technologies that reduce carbon footprint, save money and enhance public image. Sparta products solve problems by leveraging Web 3, such as artificial intelligence, blockchain and machine learning to fast-track the transition toward a sustainable future.

With Sparta, businesses can optimize their energy usage, upcycle electronic waste and accelerate health technologies, such as autonomous medicine. Sparta operates with three divisions -- environment, innovation and energy. These divisions deliver customized solutions to fit each client's needs.

Sparta is the only North American company to provide verified, high-quality carbon credits to customers through electronic waste processing at its facilities in Toronto, Canada, and Oman (Arabian Peninsula).

We seek Safe Harbor.